TARRYTOWN, N.Y., Oct. 10, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that it will report its third quarter 2013 financial and operating results on Tuesday, November 5, 2013, before the U.S. financial markets open. The Company......
More...
